Headlines

Natural Health Trends Corp. And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – Natural Health Trends Corp. (NHTC), National Health Investors (NHI), Kellogg Company (K) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Natural Health Trends Corp. (NHTC)

1333.33% Payout Ratio

Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as anti-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; and infant and toddler bath, oral care, hair care, and body care products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.

Earnings Per Share

As for profitability, Natural Health Trends Corp. has a trailing twelve months EPS of $0.06.

PE Ratio

Natural Health Trends Corp. has a trailing twelve months price to earnings ratio of 95.24. Meaning, the purchaser of the share is investing $95.24 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.29%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Natural Health Trends Corp.’s EBITDA is 24.8.

Volume

Today’s last reported volume for Natural Health Trends Corp. is 2160 which is 85.11% below its average volume of 14511.

Moving Average

Natural Health Trends Corp.’s value is above its 50-day moving average of $5.37 and way above its 200-day moving average of $4.80.

2. National Health Investors (NHI)

172.25% Payout Ratio

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

National health investors (nhi) Q2 FFO and revenues miss estimatesWhile National Health Investors has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Compared to estimates, national health investors (nhi) Q2 earnings: A look at key metricsFor the quarter ended June 2023, National Health Investors (NHI Quick QuoteNHI – Free Report) reported revenue of $66.08 million, up 37.9% over the same period last year. , Here is how National Health Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, National Health Investors has a trailing twelve months EPS of $2.09.

PE Ratio

National Health Investors has a trailing twelve months price to earnings ratio of 26.33. Meaning, the purchaser of the share is investing $26.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.

3. Kellogg Company (K)

97.11% Payout Ratio

Kellogg Company, together with its subsidiaries, manufactures and markets snacks and convenience foods. The company operates through four segments: North America, Europe, Latin America, and Asia Middle East Africa. Its principal products include crackers, crisps, savory snacks, toaster pastries, cereal bars, granola bars and bites, ready-to-eat cereals, frozen waffles, veggie foods, and noodles. The company offers its products under the Kellogg's, Cheez-It, Pringles, Austin, Parati, RXBAR, Kashi, Bear Naked, Eggo, Morningstar Farms, Choco Krispies, Crunchy Nut, Nutri-Grain, Special K, Squares, Zucaritas, Sucrilhos, Pop-Tarts, K-Time, Sunibrite, Split Stix, Be Natural, LCMs, Coco Pops, Frosties, Krave, Rice Krispies Treats, Kashi Go, Crunchy Nut, Rice Krispies Squares, Incogmeato, Veggitizers, and Gardenburger brand names. It sells its products to retailers through direct sales forces, as well as brokers and distributors. Kellogg Company was founded in 1906 and is headquartered in Battle Creek, Michigan.

Earnings Per Share

As for profitability, Kellogg Company has a trailing twelve months EPS of $2.42.

PE Ratio

Kellogg Company has a trailing twelve months price to earnings ratio of 26.27. Meaning, the purchaser of the share is investing $26.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.15%.

Yearly Top and Bottom Value

Kellogg Company’s stock is valued at $63.56 at 08:23 EST, under its 52-week low of $63.74.

Volume

Today’s last reported volume for Kellogg Company is 1846030 which is 23.92% below its average volume of 2426630.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 5.9% and a negative 3%, respectively.

4. Royal Bank Of Canada (RY)

51.38% Payout Ratio

Royal Bank of Canada operates as a diversified financial service company worldwide. The company's Personal & Commercial Banking segment offers checking and savings accounts, home equity financing, personal lending, private banking, indirect lending, including auto financing, mutual funds and self-directed brokerage accounts, guaranteed investment certificates, credit cards, and payment products and solutions; and lending, leasing, deposit, investment, foreign exchange, cash management, auto dealer financing, trade products, and services to small and medium-sized commercial businesses. This segment offers financial products and services through branches, automated teller machines, and mobile sales network. Its Wealth Management segment provides a suite of advice-based solutions and strategies to high net worth and ultra-high net worth individuals, and institutional clients. The company's Insurance segment offers life, health, home, auto, travel, wealth, annuities, and reinsurance advice and solutions; and business insurance services to individual, business, and group clients through its advice centers, RBC insurance stores, and mobile advisors; digital, mobile, and social platforms; independent brokers; and travel partners. Its Investor & Treasury Services segment provides asset servicing, custody, payments, and treasury services to financial and other investors; and fund and investment administration, shareholder, private capital, performance measurement and compliance monitoring, distribution, transaction banking, cash and liquidity management, foreign exchange, and global securities finance services. The company's Capital Markets segment offers corporate and investment banking, as well as equity and debt origination, distribution, advisory services, sale, and trading services for corporations, institutional investors, asset managers, private equity firms, and governments. The company was founded in 1864 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Royal Bank Of Canada has a trailing twelve months EPS of $7.68.

PE Ratio

Royal Bank Of Canada has a trailing twelve months price to earnings ratio of 12.39. Meaning, the purchaser of the share is investing $12.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.

Moving Average

Royal Bank Of Canada’s worth is higher than its 50-day moving average of $94.68 and below its 200-day moving average of $96.55.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 51.46B for the twelve trailing months.

5. Novo Nordisk A/S (NVO)

45.75% Payout Ratio

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Earnings Per Share

As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $4.06.

PE Ratio

Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 46.52. Meaning, the purchaser of the share is investing $46.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 83.5%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27%, now sitting on 188.29B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 61.5% and 44%, respectively.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 23, 2023, the estimated forward annual dividend rate is 1.76 and the estimated forward annual dividend yield is 1.07%.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of $1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Volume

Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.

Volatility

1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.

1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.

Sales Growth

1’s sales growth is 1% for the current quarter and 1% for the next.

Leave a Reply

Your email address will not be published. Required fields are marked *